Kathleen Corey, MD, director of the Massachusetts General Hospital Fatty Liver Clinic and co-director of the Mass General Weight Center, discusses the link between obesity and the rise in liver diseases such as nonalcoholic steatohepatitis (NASH) and nonalcoholic fatty liver disease.

Threat grows from liver illness tied to obesity

13/Jun/2014

The rise of obesity in the United States has led to an increase in liver diseases and the potential for liver transplantation. Kathleen Corey, MD, director of the Massachusetts General Hospital Fatty Liver Clinic and co-director of the Mass General Weight Center discusses the danger of nonalcoholic steatohepatitis (NASH), a condition in which excess fat in the liver (nonalcoholic fatty liver disease) leads to inflammation and scarring that can result in cirrhosis, liver cancer and liver failure. Read more